vs
Side-by-side financial comparison of Organon & Co. (OGN) and OPEN TEXT CORP (OTEX). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.3B, roughly 1.1× OPEN TEXT CORP). OPEN TEXT CORP runs the higher net margin — 12.7% vs -13.6%, a 26.3% gap on every dollar of revenue. On growth, OPEN TEXT CORP posted the faster year-over-year revenue change (-0.6% vs -5.3%). OPEN TEXT CORP produced more free cash flow last quarter ($279.4M vs $96.0M). Over the past eight quarters, Organon & Co.'s revenue compounded faster (-3.6% CAGR vs -4.3%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
Open Text Corporation is a global software company that develops and sells information management software.
OGN vs OTEX — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.3B |
| Net Profit | $-205.0M | $168.1M |
| Gross Margin | 49.2% | 74.0% |
| Operating Margin | -9.8% | 22.0% |
| Net Margin | -13.6% | 12.7% |
| Revenue YoY | -5.3% | -0.6% |
| Net Profit YoY | -288.1% | -26.9% |
| EPS (diluted) | $-0.78 | $0.66 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $1.3B | ||
| Q3 25 | $1.6B | $1.3B | ||
| Q2 25 | $1.6B | $1.3B | ||
| Q1 25 | $1.5B | $1.3B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.6B | $1.3B | ||
| Q2 24 | $1.6B | $1.4B | ||
| Q1 24 | $1.6B | $1.4B |
| Q4 25 | $-205.0M | $168.1M | ||
| Q3 25 | $160.0M | $146.6M | ||
| Q2 25 | $145.0M | $28.8M | ||
| Q1 25 | $87.0M | $92.8M | ||
| Q4 24 | $109.0M | $229.9M | ||
| Q3 24 | $359.0M | $84.4M | ||
| Q2 24 | $195.0M | $248.2M | ||
| Q1 24 | $201.0M | $98.3M |
| Q4 25 | 49.2% | 74.0% | ||
| Q3 25 | 53.5% | 72.8% | ||
| Q2 25 | 54.8% | 72.3% | ||
| Q1 25 | 55.6% | 71.6% | ||
| Q4 24 | 56.3% | 73.3% | ||
| Q3 24 | 58.3% | 71.7% | ||
| Q2 24 | 58.4% | 72.5% | ||
| Q1 24 | 59.0% | 73.0% |
| Q4 25 | -9.8% | 22.0% | ||
| Q3 25 | 15.2% | 21.0% | ||
| Q2 25 | 14.4% | 13.9% | ||
| Q1 25 | 6.7% | 16.7% | ||
| Q4 24 | 8.1% | 22.2% | ||
| Q3 24 | 13.1% | 16.3% | ||
| Q2 24 | 14.6% | 14.2% | ||
| Q1 24 | 14.5% | 15.7% |
| Q4 25 | -13.6% | 12.7% | ||
| Q3 25 | 10.0% | 11.4% | ||
| Q2 25 | 9.1% | 2.2% | ||
| Q1 25 | 5.8% | 7.4% | ||
| Q4 24 | 6.8% | 17.2% | ||
| Q3 24 | 22.7% | 6.6% | ||
| Q2 24 | 12.1% | 18.2% | ||
| Q1 24 | 12.4% | 6.8% |
| Q4 25 | $-0.78 | $0.66 | ||
| Q3 25 | $0.61 | $0.58 | ||
| Q2 25 | $0.56 | $0.11 | ||
| Q1 25 | $0.33 | $0.35 | ||
| Q4 24 | $0.42 | $0.87 | ||
| Q3 24 | $1.38 | $0.32 | ||
| Q2 24 | $0.75 | $0.91 | ||
| Q1 24 | $0.78 | $0.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $1.3B |
| Total DebtLower is stronger | $8.6B | $6.4B |
| Stockholders' EquityBook value | $752.0M | $4.0B |
| Total Assets | $12.9B | $13.6B |
| Debt / EquityLower = less leverage | 11.49× | 1.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $574.0M | $1.3B | ||
| Q3 25 | $672.0M | $1.1B | ||
| Q2 25 | $599.0M | $1.2B | ||
| Q1 25 | $547.0M | $1.3B | ||
| Q4 24 | $675.0M | $1.1B | ||
| Q3 24 | $763.0M | $1.0B | ||
| Q2 24 | $704.0M | $1.3B | ||
| Q1 24 | $575.0M | $1.1B |
| Q4 25 | $8.6B | $6.4B | ||
| Q3 25 | $8.8B | $6.4B | ||
| Q2 25 | $8.9B | $6.4B | ||
| Q1 25 | $9.0B | $6.4B | ||
| Q4 24 | $8.9B | $6.4B | ||
| Q3 24 | $8.7B | $6.4B | ||
| Q2 24 | $8.7B | $6.4B | ||
| Q1 24 | $8.7B | $8.4B |
| Q4 25 | $752.0M | $4.0B | ||
| Q3 25 | $906.0M | $4.0B | ||
| Q2 25 | $733.0M | $3.9B | ||
| Q1 25 | $542.0M | $4.1B | ||
| Q4 24 | $472.0M | $4.2B | ||
| Q3 24 | $493.0M | $4.1B | ||
| Q2 24 | $144.0M | $4.2B | ||
| Q1 24 | $48.0M | $4.1B |
| Q4 25 | $12.9B | $13.6B | ||
| Q3 25 | $13.6B | $13.5B | ||
| Q2 25 | $13.5B | $13.8B | ||
| Q1 25 | $13.2B | $13.8B | ||
| Q4 24 | $13.1B | $13.7B | ||
| Q3 24 | $12.8B | $13.8B | ||
| Q2 24 | $12.2B | $14.2B | ||
| Q1 24 | $11.9B | $16.4B |
| Q4 25 | 11.49× | 1.58× | ||
| Q3 25 | 9.74× | 1.61× | ||
| Q2 25 | 12.14× | 1.62× | ||
| Q1 25 | 16.52× | 1.55× | ||
| Q4 24 | 18.81× | 1.51× | ||
| Q3 24 | 17.75× | 1.55× | ||
| Q2 24 | 60.11× | 1.52× | ||
| Q1 24 | 181.54× | 2.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | $318.7M |
| Free Cash FlowOCF − Capex | $96.0M | $279.4M |
| FCF MarginFCF / Revenue | 6.4% | 21.1% |
| Capex IntensityCapex / Revenue | 3.0% | 3.0% |
| Cash ConversionOCF / Net Profit | — | 1.90× |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | $878.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.0M | $318.7M | ||
| Q3 25 | $264.0M | $147.8M | ||
| Q2 25 | $220.0M | $158.2M | ||
| Q1 25 | $75.0M | $402.2M | ||
| Q4 24 | $390.0M | $348.0M | ||
| Q3 24 | $141.0M | $-77.8M | ||
| Q2 24 | $332.0M | $185.2M | ||
| Q1 24 | $76.0M | $384.7M |
| Q4 25 | $96.0M | $279.4M | ||
| Q3 25 | $218.0M | $101.2M | ||
| Q2 25 | $181.0M | $124.0M | ||
| Q1 25 | $43.0M | $373.8M | ||
| Q4 24 | $335.0M | $306.7M | ||
| Q3 24 | $99.0M | $-117.1M | ||
| Q2 24 | $300.0M | $145.2M | ||
| Q1 24 | $30.0M | $348.2M |
| Q4 25 | 6.4% | 21.1% | ||
| Q3 25 | 13.6% | 7.9% | ||
| Q2 25 | 11.4% | 9.5% | ||
| Q1 25 | 2.8% | 29.8% | ||
| Q4 24 | 21.0% | 23.0% | ||
| Q3 24 | 6.3% | -9.2% | ||
| Q2 24 | 18.7% | 10.7% | ||
| Q1 24 | 1.8% | 24.1% |
| Q4 25 | 3.0% | 3.0% | ||
| Q3 25 | 2.9% | 3.6% | ||
| Q2 25 | 2.4% | 2.6% | ||
| Q1 25 | 2.1% | 2.3% | ||
| Q4 24 | 3.5% | 3.1% | ||
| Q3 24 | 2.7% | 3.1% | ||
| Q2 24 | 2.0% | 2.9% | ||
| Q1 24 | 2.8% | 2.5% |
| Q4 25 | — | 1.90× | ||
| Q3 25 | 1.65× | 1.01× | ||
| Q2 25 | 1.52× | 5.49× | ||
| Q1 25 | 0.86× | 4.33× | ||
| Q4 24 | 3.58× | 1.51× | ||
| Q3 24 | 0.39× | -0.92× | ||
| Q2 24 | 1.70× | 0.75× | ||
| Q1 24 | 0.38× | 3.91× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OGN
Segment breakdown not available.
OTEX
| Transferred At Point In Time | $184.2M | 14% |
| Cybersecurity Enterprise Product | $174.5M | 13% |
| Business Network Product | $159.8M | 12% |
| Business Network Cloud Services And Subscriptions | $151.4M | 11% |
| Content Cloud Services And Subscriptions | $137.9M | 10% |
| Cybersecurity SMB Consumer Product | $127.6M | 10% |
| Application Delivery Management Product | $120.1M | 9% |
| IT Operations Management Product | $113.3M | 9% |
| Professional Service And Other | $82.5M | 6% |
| Analytics Product | $58.1M | 4% |
| IT Operations Management Cloud Services And Subscriptions | $7.8M | 1% |
